• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS DEVELOPMENT LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS DEVELOPMENT LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXCC-I
Medical Device Problem Code Coagulation in Device or Device Ingredient (1096)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/23/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction clot observed in the return line.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot n269 was conducted.There were no non-conformances related to the complaint.This lot met all release requirements.A review of kit lot n269 shows no trends.Trends were reviewed for complaint categories, clot observed and alarm #17: return pressure.No trends were detected for these complaint categories.At the time of this report, the complaint investigation is still in process.A final report will be filed when the investigation is complete.(b)(4), (b)(6) 2026.
 
Event or Problem Description
The customer contacted therakos to report clots observed in the return line with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer also reported alarm #17: return pressure alarms and observed blood clotting in the return line when approximately 355 ml of whole blood had been processed.The ecp treatment was aborted, and residual blood was not returned to the patient.No product or photographs will be returned for evaluation.The patient has been reported to have been stable.No patient harm has been reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Common Device Name
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS DEVELOPMENT LIMITED
blanchardstown
dublin, D15 A P2D
EI  D15 AP2D
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
i.d.a. business park
castlerea roscommon,
EI  
Manufacturer Contact
brian stimson
1170 us highway 22
suite 302
bridgewater, NJ 08807
5852335524
MDR Report Key25103703
Report Number3036773437-2026-00048
Device Sequence Number9991518
Product Code LNR
UDI-Device Identifier00705030000029
UDI-Public(01)00705030000029(10)N269(17)261101
Combination Product (Y/N)Y
Initial Reporter CountryGM
PMA/510(K) Number
P860003
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 06/05/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberCLXCC-I
Device Lot NumberN269
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/23/2026
Supplement Date Received by Manufacturer05/07/2026
Initial Report FDA Received Date05/06/2026
Supplement Report FDA Received Date06/05/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/18/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-